Medplus Health Services Receives 'Sell' Rating from MarketsMOJO: Poor Management and Financial Performance Indicate Cause for Concern

Oct 23 2024 06:59 PM IST
share
Share Via
Medplus Health Services, a midcap retailing company, has received a 'Sell' rating from MarketsMojo due to poor management efficiency and weak financial performance. The company's low ROCE and weak ability to service debt are concerning, and it has underperformed the market. Technical analysis and high promoter share pledging also suggest a 'Sell' rating.
Medplus Health Services, a midcap retailing company, has recently received a 'Sell' rating from MarketsMOJO on October 23, 2024. This downgrade is based on several factors that indicate poor management efficiency and weak financial performance.

One of the main reasons for the 'Sell' rating is the company's low Return on Capital Employed (ROCE) of 5.42%, which signifies low profitability per unit of total capital. Additionally, the company's ability to service its debt is weak with a poor EBIT to Interest ratio of 1.29. This indicates that the company may struggle to meet its financial obligations.

Furthermore, Medplus Health Services has underperformed the market in the last year, generating negative returns of -15.54% while the market has seen a 34.58% increase. This is a cause for concern as it shows the company's inability to keep up with market trends and competition.

In terms of technical analysis, the stock is currently in a Mildly Bearish range and has shown a deteriorating trend since October 23, 2024. The MACD and Bollinger Band technical factors also suggest a Mildly Bearish outlook for the stock.

Another concerning factor is that 54.17% of the company's promoter shares are pledged. This means that in falling markets, there is additional downward pressure on the stock prices.

However, there are some positive aspects to consider. Medplus Health Services has shown healthy long-term growth with an annual growth rate of 23.57% in net sales and 21.44% in operating profit. Additionally, with a ROCE of 5.3, the stock has a Very Attractive valuation with a 3.7 Enterprise value to Capital Employed. This indicates that the stock is currently trading at a discount compared to its historical valuations.

In conclusion, while Medplus Health Services may have some potential for long-term growth, the current financial and technical indicators suggest a 'Sell' rating. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News